期刊文献+

缬沙坦联合氨氯地平治疗社区老年原发高血压合并糖尿病的疗效观察 被引量:11

Observation of Valsartan Combined with Amlodipine in the Treatment of Elderly Primary Hypertension and Diabetes in the Community
下载PDF
导出
摘要 目的探讨缬沙坦联合氨氯地平治疗社区老年原发高血压合并糖尿病的临床效果。方法选择老年高血压合并糖尿病患者60例,随机分为对照组和观察组,对照组给予氨氯地平治疗,观察组给予缬沙坦和氨氯地平治疗。观察组两组降压效果,测定治疗前后的血尿酸和空腹血糖水平。结果观察组降压效果总有效率高于对照组,差异有统计学意义(P<0.05)。观察组治疗后空腹血糖和血尿酸水平分别低于对照组治疗后空腹血糖和血尿酸水平,差异有统计学意义(P<0.05)。结论缬沙坦联合氨氯地平治疗社区老年原发性高血压合并糖尿病效果显著,降压效果显著,同时有助于控制血糖。 Objective To explore the clinical effect of valsartan combined with amlodipine in the treatment of elderly primary hypertension and diabetes in the community. Methods 60 elderly patients with hypertension and diabetes were randomly divided into control group and observation group. The control group was treated with amlodipine, and the observation group was treated with valsartan and amlodipine. The effect of blood pressure on blood uric acid and fasting blood glucose before and after treatment were measured in the two groups. Results The total effective rate of blood pressure in the observation group was higher than that of the control group, and the difference was statistically significant(P〈0.05). The fasting blood glucose and serum uric acid level in the observation group were lower than those in the control group after treatment, the difference was statistically significant(P〈0.05). Conclusion Valsartan combined with amlodipine is effective in the treatment of elderly patients with essential hypertension and diabetes mellitus.
作者 宋斌 SONG Bin(Shanghai Chongming District Samxing Town Community Health Service Center,Shanghai 202152,China)
出处 《中国医药指南》 2018年第13期38-39,共2页 Guide of China Medicine
关键词 原发性高血压 糖尿病 老年 缬沙坦 氨氯地平 Essential hypertension Diabetes Old age Valsartan Amlodipine
  • 相关文献

参考文献6

二级参考文献69

  • 1黄粤锋,陈钰仪,肖惠珍,陈仁山.高血压联合治疗优化方案探讨[J].中外医疗,2008,27(18):30-31. 被引量:5
  • 2何燕,严江涛,涂荣会,汪培华,汪道文.噻嗪类利尿剂对自发性高血压大鼠内皮型一氧化氮合酶和内皮素-1表达影响的研究[J].中国药理学通报,2006,22(5):552-555. 被引量:9
  • 3陈才顺.高血压联合用药治疗现状与展望[J].中国医药导报,2007,4(04S):93-93. 被引量:24
  • 4胡春松,胡大一.高血压治疗原则的进展及我国高血压治疗策略的特点与变化[J].中国中西医结合杂志,2007,27(4):380-382. 被引量:59
  • 5Pringle E, Phillips C, Thijs L, et al. Systolic blood pressurevariability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens, 2003,21:2251- 2257.
  • 6Webb A J, Fischer U, Mehta Z, et al. Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet,2010,375: 906-915.
  • 7Wallace SM, Yasmin N, McEniery CM, et al. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension,2007,50 : 228-233.
  • 8Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology ( ESC ). J Hypertens ,2007,25 : 1105-1187.
  • 9Wachtell K, Smith G, Gerdts E, et al. Left ventricular filling pattems in patients with systemic hypertension and left ventrieular hypertrophy ( the LIFE study). Losartan intervention for endpoint. Am J Cardiol,2000,85:466-472.
  • 10Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med,2008,359: 2417-2428.

共引文献287

同被引文献46

引证文献11

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部